Daily administration of short-acting liothyronine is associated with significant triiodothyronine excursions and fails to alter thyroid-responsive parameters

Thyroid

Volumn 26, Issue 6, 2016, Pages 770-778

  Jonklaas, Jacqueline ^a   Burman, Kenneth D ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; LEVOTHYROXINE; LIOTHYRONINE; LIPID; PLACEBO; SEX HORMONE BINDING GLOBULIN; SHORT ACTING DRUG; THYROTROPIN; THYROXINE;

ADULT; ANTHROPOMETRIC PARAMETERS; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CHRONOTHERAPY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG PREFERENCE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; ENERGY METABOLISM; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MALE; MIDDLE AGED; MONOTHERAPY; MORNING DOSAGE; OPEN STUDY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL; PLACEBO EFFECT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; TABLET; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION; TREATMENT RESPONSE; UNIVERSITY HOSPITAL; WELLBEING; YOUNG ADULT; BLOOD; COMBINATION DRUG THERAPY; DRUG ADMINISTRATION; HASHIMOTO DISEASE; HORMONE SUBSTITUTION; PROCEDURES; THYROID FUNCTION TEST; TREATMENT OUTCOME;

ADULT; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HASHIMOTO DISEASE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE; TREATMENT OUTCOME; TRIIODOTHYRONINE; YOUNG ADULT;

EID: 84975082476     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2015.0629     Document Type: Article

References (24)

1. Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RP, Rosenthal MS, Sawka AM 2014 Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid 24: 1670-1751
2. Louwerens M, Appelhof BC, Verloop H, Medici M, Peeters RP, Visser TJ, Boelen A, Fliers E, Smit JW, Dekkers OM 2012 Fatigue and fatigue-related symptoms in patients treated for different causes of hypothyroidism. Eur J Endocrinol 167: 809-815
3. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM 2002 Psychological well-being in patients on? 'adequate' doses of l-Thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol 57: 577-585
4. Wekking EM, Appelhof BC, Fliers E, Schene AH, Huyser J, Tijssen JG, Wiersinga WM 2005 Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol 153: 747-753
5. Eskelinen SI, Vahlberg TJ, Isoaho RE, Lopponen MK, Kivela SL, Irjala KM 2007 Associations of thyroid stimulating hormone and free thyroxine concentrations with health and life satisfaction in elderly adults. Endocr Pract 13: 451-457
6. Werneck de Castro JP, Fonseca TL, Ueta CB, McAninch EA, Abdalla S, Wittmann G, Lechan RM, Gereben B, Bianco AC 2015 Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine. J Clin Invest 125: 769-781
7. Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L 2006 Thyroxine-Triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 91: 2592-2599
8. Ma C, Xie J, Huang X, Wang G, Wang Y, Wang X, Zuo S 2009 Thyroxine alone or thyroxine plus triiodothyronine replacement therapy for hypothyroidism. Nucl Med Commun 30: 586-593
9. Joffe RT, Brimacombe M, Levitt AJ, Stagnaro-Green A 2007 Treatment of clinical hypothyroidism with thyroxine and triiodothyronine: a literature review and metaanalysis. Psychosomatics 48: 379-384
10. Thvilum M, Brandt F, Almind D, Christensen K, Brix TH, Hegedus L 2014 Increased psychiatric morbidity before and after the diagnosis of hypothyroidism: a nationwide register study. Thyroid 24: 802-808
11. Saravanan P, Siddique H, Simmons DJ, Greenwood R, Dayan CM 2007 Twenty-four hour hormone profiles of TSH, free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy. Exp Clin Endocrinol Diabetes 115: 261-267
12. Celi FS, ZemskovaM, Linderman JD, Babar NI, SkarulisMC, Csako G, Wesley R, Costello R, Penzak SR, Pucino F 2010 The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients. Clin Endocrinol 72: 709-715
13. Santini F, Giannetti M, Ricco I, Querci G, Saponati G, Bokor D, Rivolta G, Bussi S, Braverman LE, Vitti P, Pinchera A 2014 Steady-state serum T3 concentrations for 48 hours following the oral administration of a single dose of 3, 5, 3¢-Triiodothyronine sulfate (T3S). Endocr Pract 20: 680-689
14. Jonklaas J, Burman KD, Wang H, Latham KR 2015 Singledose T3 administration: kinetics and effects on biochemical and physiological parameters. Ther Drug Monit 37: 110-118
15. Andersen S, Bruun NH, Pedersen KM, Laurberg P 2003 Biologic variation is important for interpretation of thyroid function tests. Thyroid 13: 1069-1078
16. Brabant G, Brabant A, Ranft U, Ocran K, Köhrle J, Hesch RD, von zur Mühlen A 1987 Circadian and pulsatile thyrotropin secretion in euthyroid man under the influence of thyroid hormone and glucocorticoid administration. J Clin Endocrinol Metab 65: 83-88
17. Azukizawa M, Pekary AE, Hershman JM, Parker DC 1976 Plasma thyrotropin, thyroxine, and triiodothyronine relationships in man. J Clin Endocrinol Metab 43: 533-542
18. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr 1999 Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 340: 424-429
19. Panicker V, Saravanan P, Vaidya B, Evans J, Hattersley AT, Frayling TM, Dayan CM 2009 Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab 94: 1623-1629
20. Hoermann R, Midgley JE, Larisch R, Dietrich JW 2015 Integration of peripheral and glandular regulation of triiodothyronine production by thyrotropin in untreated and thyroxine-Treated subjects. Horm Metab Res 47: 674-680
21. Escobar-Morreale HF, del Rey FE, Obregon MJ, de Escobar GM 1996 Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology 137: 2490-2502
22. Escobar-Morreale HF, Obregon MJ, Escobar del Rey F, Morreale de Escobar G 1995 Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. J Clin Invest 96: 2828-2838
23. Celi FS, Zemskova M, Linderman JD, Smith S, Drinkard B, Sachdev V, Skarulis MC, Kozlosky M, Csako G, Costello R, Pucino F 2011 Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine. J Clin Endocrinol Metab 96: 3466-3474
24. Midgley JEM, Larisch, R, Dietrich, JW, Hoermann, R 2015 Variation in the biochemical response to L-Thyroxine therapy and relationship with peripheral thyroid hormone conversion efficiency. Endocr Connect 4: 196-205